Literature DB >> 22493011

Amphiregulin-dependent mucous cell metaplasia in a model of nonallergic lung injury.

Nicholas D Manzo1, W Michael Foster, Barry R Stripp.   

Abstract

Proliferation and differentiation of the pulmonary epithelium after injury is a critical process in the defense against the external environment. Defects in this response can result in airway remodeling, such as mucus cell metaplasia (MCM), commonly seen in patients with chronic lung disease. We have previously shown that amphiregulin (AREG), a ligand to the epidermal growth factor receptor (EGFR), is induced during the repair/differentiation process elicited by naphthalene-induced lung injury. Thus, we hypothesized that AREG signaling plays an important role in epithelial proliferation and differentiation of the repairing airway. Mice deficient in AREG and lung epithelial EGFR were used to define roles for AREG-dependent EGFR signaling in airway repair and remodeling. We show that AREG and epithelial EGFR expression is dispensable to pulmonary epithelial repair after naphthalene-induced lung injury, but regulates secretory cell differentiation to a mucus-producing phenotype. We show that the pulmonary epithelium is the source of AREG, suggesting that naphthalene-induced MCM is mediated through an autocrine signaling mechanism. However, induction of MCM resulting from allergen exposure was independent of AREG. Our data demonstrate that AREG-dependent EGFR signaling in airway epithelial cells contributes to MCM in naphthalene-induced lung injury. We conclude that AREG may represent a determinant of nonallergic chronic lung diseases complicated by MCM.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22493011      PMCID: PMC3488692          DOI: 10.1165/rcmb.2011-0257OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  63 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Interleukin-13 induces proliferation of human airway epithelial cells in vitro via a mechanism mediated by transforming growth factor-alpha.

Authors:  B W Booth; K B Adler; J C Bonner; F Tournier; L D Martin
Journal:  Am J Respir Cell Mol Biol       Date:  2001-12       Impact factor: 6.914

Review 3.  Untangling the ErbB signalling network.

Authors:  Y Yarden; M X Sliwkowski
Journal:  Nat Rev Mol Cell Biol       Date:  2001-02       Impact factor: 94.444

4.  Relationship of epidermal growth factor receptors to goblet cell production in human bronchi.

Authors:  K Takeyama; J V Fahy; J A Nadel
Journal:  Am J Respir Crit Care Med       Date:  2001-02       Impact factor: 21.405

5.  Expression of growth factors by airway epithelial cells in a model of chronic asthma: regulation and relationship to subepithelial fibrosis.

Authors:  R K Kumar; C Herbert; P S Foster
Journal:  Clin Exp Allergy       Date:  2004-04       Impact factor: 5.018

6.  Terminal bronchioles harbor a unique airway stem cell population that localizes to the bronchoalveolar duct junction.

Authors:  Adam Giangreco; Susan D Reynolds; Barry R Stripp
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

Review 7.  Mucociliary transport and cough in humans.

Authors:  W Michael Foster
Journal:  Pulm Pharmacol Ther       Date:  2002       Impact factor: 3.410

8.  Autocrine ligands for the epidermal growth factor receptor mediate interleukin-8 release from bronchial epithelial cells in response to cigarette smoke.

Authors:  Audrey Richter; Rory A O'Donnell; Robert M Powell; Michael W Sanders; Stephen T Holgate; Ratko Djukanović; Donna E Davies
Journal:  Am J Respir Cell Mol Biol       Date:  2002-07       Impact factor: 6.914

9.  Interleukin-13 mediates a fundamental pathway for airway epithelial mucus induced by CD4 T cells and interleukin-9.

Authors:  Laurie Whittaker; Naiqian Niu; U-Angela Temann; Amy Stoddard; Richard A Flavell; Anuradha Ray; Robert J Homer; Lauren Cohn
Journal:  Am J Respir Cell Mol Biol       Date:  2002-11       Impact factor: 6.914

10.  IL-13-induced Clara cell secretory protein expression in airway epithelium: role of EGFR signaling pathway.

Authors:  Suil Kim; Jae Jeong Shim; Pierre-Regis Burgel; Iris F Ueki; Trang Dao-Pick; Dominic Cheng-Wei Tam; Jay A Nadel
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-07       Impact factor: 5.464

View more
  15 in total

1.  Alveolar Epithelial A2B Adenosine Receptors in Pulmonary Protection during Acute Lung Injury.

Authors:  Sandra Hoegl; Kelley S Brodsky; Michael R Blackburn; Harry Karmouty-Quintana; Bernhard Zwissler; Holger K Eltzschig
Journal:  J Immunol       Date:  2015-07-17       Impact factor: 5.422

2.  BAL Cell Gene Expression in Severe Asthma Reveals Mechanisms of Severe Disease and Influences of Medications.

Authors:  Nathaniel Weathington; Michael E O'Brien; Josiah Radder; Thomas C Whisenant; Eugene R Bleecker; William W Busse; Serpil C Erzurum; Benjamin Gaston; Annette T Hastie; Nizar N Jarjour; Deborah A Meyers; Jadranka Milosevic; Wendy C Moore; John R Tedrow; John B Trudeau; Hesper P Wong; Wei Wu; Naftali Kaminski; Sally E Wenzel; Brian D Modena
Journal:  Am J Respir Crit Care Med       Date:  2019-10-01       Impact factor: 21.405

3.  DUOX1 mediates persistent epithelial EGFR activation, mucous cell metaplasia, and airway remodeling during allergic asthma.

Authors:  Aida Habibovic; Milena Hristova; David E Heppner; Karamatullah Danyal; Jennifer L Ather; Yvonne Mw Janssen-Heininger; Charles G Irvin; Matthew E Poynter; Lennart K Lundblad; Anne E Dixon; Miklos Geiszt; Albert van der Vliet
Journal:  JCI Insight       Date:  2016-11-03

4.  Macrophage-intrinsic DUOX1 contributes to type 2 inflammation and mucus metaplasia during allergic airway disease.

Authors:  Carolyn R Morris; Aida Habibovic; Christopher M Dustin; Caspar Schiffers; Miao-Chong Lin; Jennifer L Ather; Yvonne M W Janssen-Heininger; Matthew E Poynter; Olaf Utermohlen; Martin Krönke; Albert van der Vliet
Journal:  Mucosal Immunol       Date:  2022-06-02       Impact factor: 8.701

5.  Tissue remodeling by an opportunistic pathogen triggers allergic inflammation.

Authors:  Karen Agaronyan; Lokesh Sharma; Bharat Vaidyanathan; Keith Glenn; Shuang Yu; Charles Annicelli; Talia D Wiggen; Mitchell R Penningroth; Ryan C Hunter; Charles S Dela Cruz; Ruslan Medzhitov
Journal:  Immunity       Date:  2022-04-27       Impact factor: 43.474

6.  Human neutrophil elastase-mediated goblet cell metaplasia is attenuated in TACE-deficient mice.

Authors:  Jin-Ah Park; Asma S Sharif; Tetsuya Shiomi; Lester Kobzik; David I Kasahara; Daniel J Tschumperlin; Judith Voynow; Jeffrey M Drazen
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-04-05       Impact factor: 5.464

7.  EGF-Amphiregulin Interplay in Airway Stem/Progenitor Cells Links the Pathogenesis of Smoking-Induced Lesions in the Human Airway Epithelium.

Authors:  Wu-Lin Zuo; Jing Yang; Kazunori Gomi; IonWa Chao; Ronald G Crystal; Renat Shaykhiev
Journal:  Stem Cells       Date:  2016-11-17       Impact factor: 6.277

8.  Inhibition of Gabrp reduces the differentiation of airway epithelial progenitor cells into goblet cells.

Authors:  An Wang; Qiuyang Zhang; Yongmei Wang; Xue Li; Kuan Li; Yu Li; Jianhai Wang; Li Li; Huaiyong Chen
Journal:  Exp Ther Med       Date:  2021-05-03       Impact factor: 2.447

9.  IL-33 promotes an innate immune pathway of intestinal tissue protection dependent on amphiregulin-EGFR interactions.

Authors:  Laurel A Monticelli; Lisa C Osborne; Mario Noti; Sara V Tran; Dietmar M W Zaiss; David Artis
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-04       Impact factor: 11.205

10.  Epidermal Growth Factor Removal or Tyrphostin AG1478 Treatment Reduces Goblet Cells & Mucus Secretion of Epithelial Cells from Asthmatic Children Using the Air-Liquid Interface Model.

Authors:  Jeremy C Parker; Isobel Douglas; Jennifer Bell; David Comer; Keith Bailie; Grzegorz Skibinski; Liam G Heaney; Michael D Shields
Journal:  PLoS One       Date:  2015-06-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.